Services fixated on our customer's most basic issues and openings with upgraded procedures for a strong situation in the pharmaceutical industry landscape
Learn More
Access the Healthcare industry opportunities with our noteworthy experiences and vital solutions, including customized reports and the latest trends of the market
Learn More
A user-friendly dashboard that allows the customer to enjoy the entire platform exploration experience and provides the key to unlocking the door to market
Learn MoreAt DelveInsight, we are constantly focused on giving unambiguous solutions for our customer's questions. We trust in offering some benefit to our clients and assisting them with speeding up their business development.
We have over 5000 research reports in the healthcare industries covering 27 therapeutic and keeping clients informed about the most recent trends, news, and developments in the healthcare business.
Business Consulting
Market Analysis
Competitive Intelligencet
Business Development
Asset Prioritization
R&D Analysis
Get in touch with us in case of any query by submitting the following details. You can also follow us on social media to stay updated.
Analyzing the best potential asset for development & commercialization for a higher return
Valuable business insights to aid the company's success in the fast-paced pharma industry
Extensive research to understand the nuances of winning guidelines across geographies
Clarified analysis for a comprehensive understanding of indication based market patterns
Identify conceivable market opportunities and threats to practice a streamlined methodology
Licensing consultancy services to help with drug research and commercialization milestones
Well examined market knowledge for safe allocation of resources to provide a max market boost
Recognizes benefits, liabilities, dangers, and openings for increased and raised certainty
Consistent combination of blended entities to use best business profile for expanded execution
Access special accomplice and collaboration services to help with business growth
Customized research services with strategies for gaining solid traction in the industry
Analyze information about industry players and their potential moves to compete in the market
Keep up with our most recent trending topics on a variety of healthcare subjects and analysis providing insights into the healthcare domain
Take a sneak peek into our latest healthcare reports and press releases to get updated with the latest happenings in the healthcare domain
The market is anticipated to reach USD 5.5 Billion by 2026, estimates DelveInsight.
The market is growing at a CAGR of 6.41% and will hit USD 10.08 Billion by 2026,
The market size is expected to grow at a CAGR of 5.31% during the study period 2018-30
New and emerging pipeline therapies are expected to change the Polymyositis treatment outlook
Globally, around 5+ key companies are developing therapies for West Syndrome treatment
Globally, key players such as Gilead, GSK, Janssen, Merck, and others are developing therapies for HIV 1
On August 16, 2021, the FDA approved Abbott's AMPLATZER Amulet Left Atrial Appendage (LAA) Occluder to treat people with atrial fibrillation who are at risk of ischemic stroke. The device provides immediate closure of the LAA.
AMPLATZER Amulet Left Atrial Appendage Occluder has up to 50% share of the total market in Europe since approval, giving Abbott confidence to capture the same in the US market. The estimated market size for left atrial appendage in the US is around USD 500 million.
Learn More
Brainscope is the first and the only approved medical device that gives an accurate and objective assessment for both brain bleeding and concussion. The device received approval for commercialization under the name Ahead 300 by the FDA in September 2016.
It was launched in January 2017 and received 510(k) certification from the FDA for clinical usage in May 2018, when the device was rebranded as BrainScope One. Again in the year 2019, BrainScope received FDA clearance for the purpose of additional labeling to involve terminologies such as ‘multi-modal and ‘multi-parameter assessment of concussion and mild traumatic brain injury.
Learn More
428, Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
Office Telephone : +91-11-45689769
Mobile : +91-9650213330
mail : info@delveinsight.co.uk
